Chlorzoxazone Tablet
Product Images NDC 16571-727

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Chlorzoxazone (NDC 16571-727). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rising Pharma Holdings, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chlorzoxazone-375 (Chlorzoxazone 375)

Chlorzoxazone Tablets, USP with a strength of 375 mg and quantity of 100 tablets, with instructions for dispensing its contents in a child-resistant closure and tight container for maximum safety. For full prescribing information, see the package insert. Store at room temperature and keep tightly closed. Manufactured by Gravii Pharmaceuticals Pvt. Ltd in India for Rising Pharma Holdings, Inc. of New Jersey.*

FDA Label Image

Chlorzoxazone-500 (Chlorzoxazone 500)

This is a description of a medication package of Chlorzoxazone Tablets, USP of 500mg, containing 100 tablets with usual dosage recommended on the package insert. The medication is meant to be kept in a child-resistant container, away from the children and stored under controlled room temperature. The package has been manufactured by Rising Pharma Holdings, Inc. in East Brunswick, NJ, and manufactured by Graviti Pharmaceuticals Pvt. Ltd. in Tolangana, India. The package also provides specific details of manufacturing and licensing numbers.*

FDA Label Image

Chlorzoxazone-750 (Chlorzoxazone 750)

PMRising NDC 16571-727-01 Each tablet contains Chlorzoxazone USP 750mg. This is a bulk package to be dispensed with a child-resistant closure and stored in a tight container. Keep all medications out of reach of children. Usual dosage is provided in the package insert. Store between 20° to 25°C (68° to 77°F). This product is manufactured by Graviti Pharmaceuticals Pvt Ltd in India and is licensed by 12/SRDITS/2017/F1G. The manufacturing date is revised as 0372022, and the product has an LR72701-01 number and a unique unvarnished area measurement of 50x15mm.*

FDA Label Image

Struct (Struct)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.